These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
861 related articles for article (PubMed ID: 3365983)
1. The interaction of alcohol consumption and oral contraceptive use on lipids and lipoproteins. Kruszon-Moran D; Burkman RT; Kimball AW; Bachorik PS; Gold EB Contraception; 1988 Jan; 37(1):39-51. PubMed ID: 3365983 [TBL] [Abstract][Full Text] [Related]
2. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids. Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162 [TBL] [Abstract][Full Text] [Related]
3. Serum lipid and lipoprotein changes induced by new oral contraceptives containing ethinylestradiol plus levonorgestrel or desogestrel. Gaspard UJ; Buret J; Gillain D; Romus MA; Lambotte R Contraception; 1985 Apr; 31(4):395-408. PubMed ID: 3159546 [TBL] [Abstract][Full Text] [Related]
4. Fasting plasma lipids, lipoproteins and apolipoproteins in Nigerian women using combined oral and progestin-only injectable contraceptives. Oyelola OO Contraception; 1993 May; 47(5):445-54. PubMed ID: 8513671 [TBL] [Abstract][Full Text] [Related]
5. Effect of two oral contraceptives containing ethinyl estradiol and gestodene or norgestimate on different lipid and lipoprotein parameters. Wiegratz I; Jung-Hoffmann C; Gross W; Kuhl H Contraception; 1998 Aug; 58(2):83-91. PubMed ID: 9773262 [TBL] [Abstract][Full Text] [Related]
6. Oral contraceptive tablets containing 20 and 30 micrograms of ethinyl estradiol with 150 micrograms desogestrel. Their influence on lipids, lipoproteins, sex hormone binding globulin and testosterone. Akerlund M; Almström E; Högstedt S; Nabrink M Acta Obstet Gynecol Scand; 1994 Feb; 73(2):136-43. PubMed ID: 8116352 [TBL] [Abstract][Full Text] [Related]
7. Effects of long-term administration of an oral contraceptive containing ethinylestradiol and cyproterone acetate on lipid metabolism in women with polycystic ovary syndrome. Falsetti L; Pasinetti E Acta Obstet Gynecol Scand; 1995 Jan; 74(1):56-60. PubMed ID: 7856434 [TBL] [Abstract][Full Text] [Related]
8. Effects of desogestrel and gestodene in low-dose oral contraceptive combinations on lipid and lipoprotein status. A randomized prospective study. Granata A; Sobbrio GA; D'Arrigo F; Barillari M; Curasì MP; Egitto M; Trimarchi F; Granese D; Pullè C Acta Eur Fertil; 1990; 21(3):143-6. PubMed ID: 2149913 [TBL] [Abstract][Full Text] [Related]
9. Associations of oral contraceptive use with serum lipids and lipoproteins in young women: the Bogalusa Heart Study. Greenlund KJ; Webber LS; Srinivasan S; Wattigney W; Johnson C; Berenson GS Ann Epidemiol; 1997 Nov; 7(8):561-7. PubMed ID: 9408552 [TBL] [Abstract][Full Text] [Related]
10. The effect of triphasic and biphasic oral contraceptive preparations on HDL-cholesterol and LDL-cholesterol in young women. Percival-Smith RK; Morrison BJ; Sizto R; Abercrombie B Contraception; 1987 Feb; 35(2):179-87. PubMed ID: 3595143 [TBL] [Abstract][Full Text] [Related]
11. Oral contraceptive and postmenopausal estrogen effects on lipoprotein triglyceride and cholesterol in an adult female population: relationships to estrogen and progestin potency. Knopp RH; Walden CE; Wahl PW; Hoover JJ; Warnick GR; Albers JJ; Ogilvie JT; Hazzard WR J Clin Endocrinol Metab; 1981 Dec; 53(6):1123-32. PubMed ID: 7298796 [TBL] [Abstract][Full Text] [Related]
12. Clinical and metabolic study of a new pill containing 20 mcg ethinylestradiol plus 0.150 mg desogestrel. Fioretti P; Fruzzetti F; Navalesi R; Ricci C; Miccoli R; Cerri M; Orlandi MC; Melis GB Contraception; 1987 Mar; 35(3):229-43. PubMed ID: 2956055 [TBL] [Abstract][Full Text] [Related]
13. Lipid and lipoprotein changes during the seven days off oral contraception in women using two triphasic preparations. Percival-Smith RK; Frohlich J; Jones WN; Abercrombie BA Contraception; 1988 Jul; 38(1):19-26. PubMed ID: 3168443 [TBL] [Abstract][Full Text] [Related]
14. [Lipids, lipoproteins, arterial accidents and oral contraceptives]. Bakir R; Hilliquin P Contracept Fertil Sex (Paris); 1986 Jan; 14(1):81-7. PubMed ID: 12341243 [TBL] [Abstract][Full Text] [Related]
15. Effects of three low-dose oral contraceptive formulations on lipid metabolism. Bertolini S; Elicio N; Cordera R; Gapitanio GL; Montagna G; Croce S; Saturnino M; Balestreri R; De Cecco L Acta Obstet Gynecol Scand; 1987; 66(4):327-32. PubMed ID: 2962417 [TBL] [Abstract][Full Text] [Related]
16. Serum apolipoprotein A-I levels: relationship to lipoprotein lipid levels and selected demographic variables. Phillips NR; Havel RJ; Kane JP Am J Epidemiol; 1982 Aug; 116(2):302-13. PubMed ID: 6810694 [TBL] [Abstract][Full Text] [Related]
17. The effects of Implanon on lipid metabolism in comparison with Norplant. Suherman SK; Affandi B; Korver T Contraception; 1999 Nov; 60(5):281-7. PubMed ID: 10717780 [TBL] [Abstract][Full Text] [Related]
18. Effects of oral contraceptives on serum lipid profiles of women runners. Gray DP; Harding E; Dale E Fertil Steril; 1983 Apr; 39(4):510-4. PubMed ID: 6832406 [TBL] [Abstract][Full Text] [Related]
19. A prospective, one-year study on the effects of two long acting injectable contraceptives (depot-medroxyprogesterone acetate and norethisterone oenanthate) on serum and lipoprotein lipids. Enk L; Landgren BM; Lindberg UB; Silfverstolpe G; Crona N Horm Metab Res; 1992 Feb; 24(2):85-9. PubMed ID: 1533383 [TBL] [Abstract][Full Text] [Related]
20. Metabolic profile of six oral contraceptives containing norgestimate, gestodene, and desogestrel. Teichmann A Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():98-104. PubMed ID: 8574257 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]